Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.
In humans and animal models of atherosclerosis, antibodies against oxidized LDL have been associated with atherosclerotic lesion development. It has been suggested that IgM anti-oxLDL antibodies are anti-atherogenic, whereas IgG anti-oxLDL antibodies are pro-atherogenic. In this study, we examined the relation between IgM and IgG antibody levels and atherosclerosis severity in APOE(-/-)CD40L(-/-) mice, which are deficient for IgG and develop moderate advanced atherosclerosis, and compared results with mice developing severe (APOE(-/-)) or no atherosclerosis (C57Bl/6). Mice were followed in time for anti-oxLDL antibodies while on high-fat diet or normal chow. Anti-oxLDL antibody levels were determined by ELISA. Results revealed that 24-week-old APOE(-/-)CD40L(-/-) mice had enhanced IgM anti-oxLDL antibody levels when compared with wild-type mice, but similar levels to those of APOE(-/-) mice. As expected, IgG anti-oxLDL antibody levels were almost absent in APOE(-/-)CD40L(-/-) mice. The transition from early to advanced lesions in APOE(-/-) mice was reflected by elevated IgM anti-oxLDL antibody levels. IgM anti-oxLDL levels did not further increase during progression to more advanced lesions. No relation was found between IgG anti-oxLDL levels and atherosclerosis severity. In conclusion, the severity of advanced atherosclerosis in mice is not reflected by IgM and/or IgG anti-oxLDL antibody levels. Furthermore, less advanced atherosclerotic lesion development in APOE(-/-)CD40L(-/-) mice does not seem to be the result of higher levels of protective IgM anti-oxLDL antibodies. Therefore, our study does not support the idea that the previously observed inconsistency in the relation between anti-oxLDL and atherosclerosis severity is due to differences in antibody isotypes.
Smook
M L F
ML
Department of Internal Medicine, Section Clinical & Experimental Immunology, Maastricht University, Maastricht, The Netherlands.
van Leeuwen
M
M
Heeringa
P
P
Damoiseaux
J G M C
JG
Theunissen
R
R
Daemen
M J A P
MJ
Lutgens
E
E
Tervaert
J W Cohen
JW
D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics; D050197:Atherosclerosis / Q000175:diagnosis* / Q000276:immunology; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D023201:CD40 Ligand / Q000235:genetics; D004195:Disease Models, Animal; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D008077:Lipoproteins, LDL / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout
D001057:Apolipoproteins E; D001323:Autoantibodies; D015415:Biomarkers; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D023201:CD40 Ligand
Int J Clin Lab Res. 1993;23(2):95-101
8518420
Curr Opin Lipidol. 1998 Oct;9(5):471-4
9812202
Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):990-9
7600130
Nat Med. 2002 Nov;8(11):1211-7
12411947
Free Radic Biol Med. 2001 Sep 15;31(6):769-77
11557315
Atherosclerosis. 1985 Oct;57(1):65-73
3841001
Arterioscler Thromb. 1994 Jan;14(1):32-40
7506053
Arterioscler Thromb. 1994 Jan;14(1):133-40
8274468
Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):703-7
10712394
Nat Med. 2003 Jun;9(6):736-43
12740573
Circulation. 2004 Oct 26;110(17):2552-8
15505108
Arteriosclerosis. 1990 May-Jun;10(3):325-35
1693068
Cell. 1992 Oct 16;71(2):343-53
1423598
Arterioscler Thromb. 1994 Apr;14(4):605-16
7511933
J Clin Invest. 2002 Mar;109(6):745-53
11901183
J Clin Invest. 1998 Apr 15;101(8):1717-25
9541503
Anal Biochem. 1975 May 12;65(1-2):42-9
165752
Arterioscler Thromb Vasc Biol. 2001 Aug;21(8):1333-9
11498462
J Clin Invest. 1999 Jan;103(1):117-28
9884341
J Clin Invest. 2004 Aug;114(3):427-37
15286809
Nature. 2000 Sep 14;407(6801):233-41
11001066
Proc Natl Acad Sci U S A. 1989 Feb;86(4):1372-6
2465552
Atherosclerosis. 2007 Jan;190(1):10-1
16774756
Am J Physiol Regul Integr Comp Physiol. 2006 Dec;291(6):R1644-50
16825416
Lancet. 1992 Apr 11;339(8798):883-7
1348295
Arterioscler Thromb. 1994 Sep;14(9):1480-97
8068611
Trends Cardiovasc Med. 2001 Apr-May;11(3-4):93-102
11686009
Arterioscler Thromb Vasc Biol. 1999 Jul;19(7):1600-7
10397676
Arterioscler Thromb Vasc Biol. 1995 Apr;15(4):441-5
7749854
Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):821-5
7846059
Nat Med. 1999 Nov;5(11):1313-6
10546000
Science. 1992 Oct 16;258(5081):468-71
1411543
Arterioscler Thromb. 1994 Jan;14(1):141-7
8274470
Free Radic Biol Med. 1995 Jun;18(6):1087-91
7628731
Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2533-8
11116049
Physiol Rev. 2004 Oct;84(4):1381-478
15383655